Epidemiology and Market Size
Our Epidemiology and Market Size Database can be purchased on a standalone basis or together with other modules or solutions across our full portfolio to create an integrated, tailor-made research platform.
GlobalData’s Epidemiology and Market Size Database provides an interactive, comprehensive, and analytical view of the pharmaceutical market in key countries.
The database has a user-friendly platform that provides flexible data output options. For each indication, content can be browsed by individual countries or by data type. Output data can be graphically displayed by clicking the “graph” button. It covers over 120 indications in 17 therapy areas across key markets, including the US, Japan,
France, Germany, Italy, Spain, and the UK. Additional markets, such as Canada, Brazil, India, and China, are covered if their markets are highly relevant to an indication.
For each indication, the database offers country-specific forecasts for prevalent and/or incident cases, number of cases treated,
market size, and other data relevant to the indication.
GlobalData uses a patient-based forecasting model to determine the market size for therapeutic indications. Estimates are based on a number of primary research sources,
including key opinion leader (KOL) interviews and prescriber surveys, as well as secondary research sources, such as company reports, press releases, published articles,
proprietary databases, and general news media. Data for the base year and forecast years of the model are grounded in the epidemiology and market parameters, with top-
down validation of the base-year market using company-reported sales.
Clear navigation flow, transparent methodology and easy-to-use database
- Data integrates throughout the model for easy navigation
- Filter data by a specific country of interest with our new View by Country option
- Special populations are indicated in the data type drop-down menu
- Patient segmentations are specified in the Advanced Options menu, as well as in output tables
Why choose the Epidemiology and Market Size Database?
The database provides you with accurate forecast data. Relevant and detailed patient segmentations are provided for each indication, enabling you to evaluate the commercial potential of the market. Refined methodology with focus on granularity and patient segmentations is provided, while methodology is consistent across all markets to ensure comparability of patient populations.
The bottom-up approach based on population estimates and epidemiology data supports the analysis of unmet needs. Prevalence and incidence data are presented in five-year age groups, allowing for a more detailed view of patient population characteristics. In addition, extensive training sessions for all departments available through a dedicated account manager.
Who can the Epidemiology and Market Size Database help?
Pharmaceutical and biotechnology companies, venture capital and private equity firms, and investment banks can benefit from the database.